Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 183

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The haematocrit and platelet target in polycythemia vera

Open access
Di Nisio, Marcello, Barbui, Tiziano, Di Gennaro, Leonardo, Borrelli, Giovanna, Finazzi, Guido, Landolfi, Raffaele, Leone, Giuseppe, Marfisi, RosaMaria, Porreca, Ettore, Ruggeri, Marco, Rutjes, Anne W. S., Tognoni, Gianni, Vannucchi, Alessandro M., Marchioli, Roberto, the European Collaboration on Low‐dose Aspirin in Polycythemia Vera (ECLAP) Investigators · 2007 · British Journal of Haematology

Abstract

Summary: Polycythemia vera (PV) is a chronic myeloproliferative disorder whose major morbidity and mortality are thrombohaemorragic events and progression to acute leukaemia or myelofibrosis. Whether the haematocrit and platelet count predict such complications remains unclear. The European Collaboration on Low‐dose Aspirin in Polycythemia Vera prospective study included 1638 PV patients. A total of 164 deaths (10%), 145 (8·85%) major thrombosis and 226 (13·8%) total thrombosis were encountered during 4393 person‐years follow‐up (median 2·8 years). In time‐dependent multivariable analysis, a haematocrit in the evaluable range of 40–55% was neither associated with the occurrence of thrombotic events, mortality nor with haematological progression in the studied population. The haematocrit of patients in the highest and lowest deciles at baseline was maintained within a narrow interval of haematocrit values ranging from 40% to 47% throughout follow‐up. High platelet count was associated with a lower progression rate to acute leukaemia/myelofibrosis, whereas it had no significant relationship with thrombotic events or mortality. Our findings do not suggest that the range of haematocrit (<55%) and platelet counts (<600 × 10 9 /l) we encountered in our population had an impact on the outcome of PV patients treated by current therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2141.2006.06430.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 183

Metadata

Authors
Di Nisio, M., Barbui, T., Di Gennaro, L., Borrelli, G., Finazzi, G., Landolfi, R., Leone, G., Marfisi, R., Porreca, E., Ruggeri, M., Rutjes, A. W. S., Tognoni, G., Vannucchi, A. M., Marchioli, R., & the European Collaboration on Low‐dose Aspirin in Polycythemia Vera (ECLAP) Investigators
Venue
British Journal of Haematology
Publisher
Wiley
Published
2006-12-08
Volume
136
Issue
2
Pages
249-259
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W2025614458
Cited by
183
References
1
FWCI
5.10
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The haematocrit and platelet target in polycythemia vera. https://app.cochat.ai/papers/10.1111/j.1365-2141.2006.06430.x
The paper
Di Nisio, M., Barbui, T., Di Gennaro, L., Borrelli, G., Finazzi, G., Landolfi, R., Leone, G., Marfisi, R., Porreca, E., Ruggeri, M., Rutjes, A. W. S., Tognoni, G., Vannucchi, A. M., Marchioli, R., & the European Collaboration on Low‐dose Aspirin in Polycythemia Vera (ECLAP) Investigators. (2007). The haematocrit and platelet target in polycythemia vera. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2006.06430.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.